Schedule 13G ownership disclosure
DRUGS MADE IN AMER ACQUTN CO
Common · CUSIP: G2847J104
Event date: 2025-06-30
- Filing-level shares
- 2,744,109.00
- Percent of class
- 8.19%
- KARPUS MANAGEMENT, INC.
Shares: 2,744,109.00 · Class: 8.19%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-25-000596
- Form type
- SCHEDULE 13G/A
- Filer
- Drugs Made In America Acquisition Corp.
- CIK
- CIK 2028614
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership